oasis 1 trial oral semaglutide 50 mg obesity lancet 2023 Efficacy, Safety and PK of Once‐Daily 25 for With and Without Type 2 Diabetes in Comparison With Subcutaneous Semaglutide 2.4 mg: A Model‐Informed Drug Development Approach The Lancet argued that 2026

Better alternatives to using expired medication If cost is the primary driver, explore these options instead: Talk to your prescriber about compounded semaglutide, which is typically much less expensive than brand-name products Check manufacturer patient assistance programs (Novo Nordisk offers several) Explore insurance coverage options, as many plans now cover GLP-1 medications Adjust your dosing schedule in consultation with your prescriber rather than stretching medication beyond its shelf life Use peptide cost calculators to compare options and find the most cost-effective approach for your protocol The bottom line

Semaglutide is most effective when used as part of a comprehensive treatment plan that includes a healthy diet and regular exercise, and not as a stand-alone quick fix

Decreased risk of anxiety in diabetic patients receiving glucagon-like peptide-1 receptor agonist: a nationwide, population-based cohort Study

Specifically, people with a personal or family history of thyroid cancer, including medullary thyroid carcinoma (MTC), should not use semaglutide GLP-1 due to an increased risk of developing thyroid tumors

2024;7:e2351322